HK1179942A1 - 皮膚增白 增亮 化合物系列 - Google Patents

皮膚增白 增亮 化合物系列

Info

Publication number
HK1179942A1
HK1179942A1 HK13107258.7A HK13107258A HK1179942A1 HK 1179942 A1 HK1179942 A1 HK 1179942A1 HK 13107258 A HK13107258 A HK 13107258A HK 1179942 A1 HK1179942 A1 HK 1179942A1
Authority
HK
Hong Kong
Prior art keywords
lightening
compounds
series
skin whitening
whitening
Prior art date
Application number
HK13107258.7A
Other languages
English (en)
Inventor
K Nandy Sandip
Liu Jiyun
Mikhailovitch Nesterov Alexandre
Hertel Carmen
A Padmapriya Abeysinghe
Original Assignee
Unigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unigen Inc filed Critical Unigen Inc
Publication of HK1179942A1 publication Critical patent/HK1179942A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/295—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
    • A23B7/00—Preservation or chemical ripening of fruit or vegetables
    • A23B7/14—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
    • A23B7/153—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
    • A23B7/154—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3481—Organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
    • C07C39/11—Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
HK13107258.7A 2008-07-21 2013-06-21 皮膚增白 增亮 化合物系列 HK1179942A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8242208P 2008-07-21 2008-07-21

Publications (1)

Publication Number Publication Date
HK1179942A1 true HK1179942A1 (zh) 2013-10-11

Family

ID=41530844

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13107258.7A HK1179942A1 (zh) 2008-07-21 2013-06-21 皮膚增白 增亮 化合物系列

Country Status (14)

Country Link
US (8) US8362305B2 (zh)
EP (3) EP4046619A1 (zh)
JP (7) JP2011528719A (zh)
KR (7) KR20200049891A (zh)
CN (2) CN102838460B (zh)
AU (5) AU2009274158C1 (zh)
BR (1) BRPI0916188A2 (zh)
CA (1) CA2730265C (zh)
ES (2) ES2909484T3 (zh)
HK (1) HK1179942A1 (zh)
PL (1) PL3542780T3 (zh)
TW (1) TWI531381B (zh)
WO (1) WO2010011630A1 (zh)
ZA (1) ZA201100043B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1748767T3 (pl) 2004-05-28 2012-08-31 Unigen Inc 1-(3-metylo-2,4-dimetoksyfenylo)-3-(2',4'-dihydroksyfenylo)-propan jako silny inhibitor tyrozynazy
JP2011528719A (ja) * 2008-07-21 2011-11-24 ユニジェン・インコーポレーテッド スキンホワイトニング（色を薄くする）化合物系列
AU2009331298B2 (en) * 2008-12-22 2015-04-30 Pola Chemical Industries Inc. Melanin production inhibitor
FR2969149B1 (fr) * 2010-12-16 2012-12-28 Oreal Procede de depigmentation des matieres keratiniques a l' aide de composes derives de resorcinol
FR2971249B1 (fr) * 2011-02-07 2013-10-18 Fabre Pierre Dermo Cosmetique Derives heterocycliques du resorcinol, leur preparation et leurs utilisations cosmetiques
KR102113823B1 (ko) * 2011-03-24 2020-05-21 유니젠, 인크. 디아릴프로판의 제조를 위한 화합물 및 방법
EP2554273A1 (en) 2011-08-02 2013-02-06 Omya Development AG Atomizing nozzle device and use of the same
FR2978660B1 (fr) * 2011-08-05 2013-09-20 Oreal Utilisation d'antagoniste du recepteur cb1 en tant qu'agent blanchissant et/ou anti-brunissement des matieres keratiniques
RU2014147075A (ru) * 2012-04-25 2016-06-10 Мерк Патент Гмбх Применение производных дициклогексилметанола с антимикробными свойствами
FR2991985B1 (fr) * 2012-06-19 2019-11-08 L'oreal Procede de depigmentation des matieres keratiniques a l'aide de nouveaux composes derives de resorcinol
JP6537788B2 (ja) * 2014-06-25 2019-07-03 ロレアル ナノエマルション若しくはマイクロエマルションの形態の又はラメラ構造を有する組成物
CN104892388B (zh) * 2015-06-10 2017-01-25 江南大学 3‑（2，4‑二羟基‑苯基）‑1，5‑二‑（2‑羟基‑苯基）‑戊烷‑1，5‑二酮的合成方法及其用途
US9738581B2 (en) * 2015-06-16 2017-08-22 Hong Kong Baptist University Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions
FR3045600B1 (fr) * 2015-12-16 2018-01-26 L'oreal Derives de resorcinol pour leur utilisation cosmetique
CN105924342B (zh) * 2016-05-18 2019-06-04 江南大学 1，5-二-（2，4-二羟基-苯基）-3-（3，4-二羟基-苯基）-戊烷-1，5-二酮的合成方法及其应用
MY187342A (en) * 2016-11-15 2021-09-22 Univ Hong Kong Baptist Univ Skin-protection composition containing dendrobium-based ingredients
FR3071731B1 (fr) * 2017-09-29 2020-06-19 L'oreal Derives de resorcinol pour leur utilisation cosmetique
CN113454054B (zh) * 2018-10-14 2024-01-02 尤尼根公司 治疗皮肤病和其他病况的一系列化合物
JP7239310B2 (ja) * 2018-12-12 2023-03-14 花王株式会社 １－フェニル－２－フェニルエタン誘導体
JP7376058B2 (ja) * 2019-01-23 2023-11-08 国立大学法人宇都宮大学 レゾルシノール誘導体およびこれを含むチロシナーゼ活性阻害剤
CN113543782B (zh) * 2019-02-01 2024-01-16 仁荷大学校产学协力团 用于防止头发变白以及预防或治疗白发症或白癜风的药物组合物
FR3095325B1 (fr) 2019-04-24 2022-05-13 Idscent Dispositif d’echantillonnage de parfum

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA238730A (en) 1924-03-18 R. Curme Henry Process of oxidising dibenzyl
US1596613A (en) * 1925-12-15 1926-08-17 Lehn & Fink Inc 2, 4-dihydroxydiphenylethane and process of making it
US2557921A (en) * 1948-01-30 1951-06-26 Universal Oil Prod Co Stabilization of edible fats and oils
US2719866A (en) * 1951-08-04 1955-10-04 Lilly Co Eli Substituted resorcinols
US3133967A (en) * 1960-02-04 1964-05-19 Boehringer Sohn Ingelheim 1-(3, 4-dialkoxy-phenol)-1-dialkylamino-3-and-4-piienyl butanes
JPS496311B1 (zh) 1970-01-09 1974-02-13
HU163394B (zh) * 1971-12-20 1973-08-28
DE2644591A1 (de) * 1976-10-02 1978-04-06 Bayer Ag Verfahren zur herstellung von arylsulfoniumsalzen
US5008294A (en) 1985-02-11 1991-04-16 Chemex Pharmaceuticals, Inc. Methods of treating tumors with compositions of catecholic butanes
US4678664A (en) * 1982-09-30 1987-07-07 Basf Corporation Mineral oil gels
EP0122523A3 (en) * 1983-04-18 1987-05-27 Andrews Paper and Chemical Co., Inc. Diazotype compositions and materials
JPS60258538A (ja) * 1984-06-06 1985-12-20 Ricoh Co Ltd ジアゾ複写材料
JPS6125137A (ja) * 1984-07-13 1986-02-04 Ricoh Co Ltd ジアゾ複写材料
US4880637A (en) 1985-02-11 1989-11-14 Chemex Pharmaceuticals, Inc. Compositions of catecholic butanes with zinc
JPS62178562A (ja) * 1986-01-30 1987-08-05 Japan Synthetic Rubber Co Ltd １，２−キノンジアジド化合物の製造方法
JPS62185037A (ja) * 1986-02-12 1987-08-13 Tsumura Juntendo Inc カルコン誘導体
JPH01501790A (ja) 1986-11-19 1989-06-22 ケメックス　ファーマシューティカルズ，インコーポレイティド リポキシゲナーゼ阻害剤
FR2609711B1 (fr) * 1987-01-21 1989-06-16 Rhone Poulenc Chimie Procede de preparation d'hydroxybiphenyles
JPH0211537A (ja) * 1988-06-30 1990-01-16 Kaken Pharmaceut Co Ltd ジヒドロカルコン誘導体の製造方法
CA1327869C (en) * 1989-02-17 1994-03-15 Yvan Guindon Ribonucleotide reductase inhibitors
JPH02273750A (ja) * 1989-04-14 1990-11-08 Hitachi Chem Co Ltd ポジ型ホトレジスト組成物およびレジストパターンの製造法
JPH03242650A (ja) * 1990-02-20 1991-10-29 Fuji Photo Film Co Ltd ポジ型フオトレジスト組成物
JPH03251494A (ja) * 1990-03-01 1991-11-08 Oji Paper Co Ltd 感熱記録体
JPH05213729A (ja) 1992-01-31 1993-08-24 Kao Corp メラニン抑制剤
US5430062A (en) 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
EP0641301A1 (en) 1992-05-21 1995-03-08 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
GB2268225B (en) 1992-06-29 1995-07-05 Ford Motor Co A fuel supply arrangement
IT1256354B (it) 1992-08-31 1995-12-01 Francesca Pelizzoni Derivati della combretastatina ad attivita' anti-tumorale e procedimento per la loro preparazione
GB9322007D0 (en) * 1993-10-26 1993-12-15 Unilever Plc Cosmetic composition
KR960015406B1 (ko) 1993-11-16 1996-11-13 주식회사 태평양 코지산 유도체
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US7056935B2 (en) * 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
JPH08337510A (ja) 1995-06-15 1996-12-24 Advanced Sukin Res Kenkyusho:Kk メラニン生成抑制剤
CN1055077C (zh) * 1995-11-24 2000-08-02 三井化学株式会社 氢化查耳酮衍生物，含有所述衍生物的化妆品组合物及其制备方法
JP3799645B2 (ja) * 1996-01-18 2006-07-19 住友化学株式会社 多価フェノール系化合物のキノンジアジドスルホン酸エステルおよびその用途
JP3799644B2 (ja) * 1996-01-18 2006-07-19 住友化学株式会社 フェノール系２核体化合物、その製法および用途
RU2156771C2 (ru) 1996-05-30 2000-09-27 Институт нефтехимии и катализа с опытным заводом АН РБ Способ совместного получения 1-(диалкиламино)-2-фенилалюмациклопропана и 1-(диалкиламино)-2,4-дифенилалюмациклопентана
JPH1072330A (ja) * 1996-09-03 1998-03-17 Kansai Kouso Kk チロシナーゼ活性阻害剤及び化粧料
KR100509878B1 (ko) 1997-02-07 2005-08-25 아벤티스 파마슈티칼스 인크. (4-피페리디닐)-1ｈ-2-벤조피란 유도체 및 이를 함유하는 정신병 치료용 약제학적 조성물
KR100270410B1 (ko) 1997-03-06 2000-11-01 성재갑 타이로시네이즈 활성 저해능을 갖는 신규 1,3-디페닐프로판 유도체 및 그의 제조방법
US6077503A (en) 1997-07-30 2000-06-20 Amway Corporation Skin whitener composition containing mercaptodextran
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.
JP3636423B2 (ja) * 1997-12-16 2005-04-06 三井化学株式会社 ハイドロカルコン誘導体を有効成分とする化粧料
JPH11255638A (ja) * 1998-03-13 1999-09-21 Kansai Kouso Kk チロシナーゼ活性阻害剤及び化粧料
JP2002524504A (ja) * 1998-09-11 2002-08-06 イレクサス・ピーティーワイ・リミテッド Ｆｃ受容体調節剤およびそれの使用
US6296857B1 (en) * 1998-09-23 2001-10-02 Beiersdorf Aktiengesellschaft Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation
JP2000095721A (ja) * 1998-09-28 2000-04-04 Mitsui Chemicals Inc 新規ハイドロカルコン誘導体、該誘導体を含む化粧料およびこれらの製造方法
AU5319700A (en) * 1999-06-02 2000-12-18 S. Mbua Ngale Efange Nicotine receptor ligands
US6214874B1 (en) * 1999-10-15 2001-04-10 John Hopkins University Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N
US6630510B1 (en) 1999-10-28 2003-10-07 Merck & Co., Inc. Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
US6221604B1 (en) * 2000-02-07 2001-04-24 Pe Corporation Electron-deficient nitrogen heterocycle-substituted fluorescein dyes
EP1267868B1 (en) * 2000-02-29 2007-07-18 MediQuest Therapeutics, Inc. Inhibitors of melanocyte tyrosinase as topical skin lighteners
JP2001335472A (ja) * 2000-05-24 2001-12-04 Kansai Koso Kk チロシナーゼ活性阻害剤及び化粧料
DE60134854D1 (de) 2000-06-30 2008-08-28 Procter & Gamble Orale zubereitungen, die wirtsantwortmodulierenden wirkstoffe enthalten
JP3504594B2 (ja) 2000-07-28 2004-03-08 株式会社ノエビア 皮膚外用剤
BR0113798A (pt) 2000-09-11 2003-07-08 Pfizer Prod Inc Derivados de resorcinol
DE60110516T2 (de) 2000-09-21 2005-10-13 Solvias Ag Phosphinite-oxazoline und Metallkomplexe
CA2423262A1 (en) * 2000-09-21 2002-03-28 Pfizer Products Inc. Resorcinol derivatives
DE10051034A1 (de) 2000-10-14 2002-04-18 Henkel Kgaa Oxidationsmittel enthaltend 2-Chlor-4-aminophenol
WO2002035580A2 (en) 2000-10-24 2002-05-02 Molecular Electronics Corporation Three-terminal field-controlled molecular devices
HU227197B1 (en) 2000-10-24 2010-10-28 Richter Gedeon Nyrt Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
JP2002193990A (ja) 2000-12-25 2002-07-10 Mitsui Chemicals Inc ハイドロカルコン配糖体および該配糖体を有効成分として配合した化粧料
ES2241999T3 (es) * 2001-05-25 2005-11-01 Wella Aktiengesellschaft Derivados de 1,3-dihidroxibenceno y productos para el teñido de fibras que los contienen.
CA2452159A1 (en) 2001-07-23 2003-02-06 Galileo Laboratories, Inc. Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
JP2003040980A (ja) * 2001-07-31 2003-02-13 Nitto Denko Corp 半導体封止用樹脂組成物およびそれを用いた半導体装置
GB0126889D0 (en) 2001-11-08 2002-01-02 Paterson Inst For Cancer Res Compounds and their uses
DE10161253A1 (de) 2001-12-13 2003-06-26 Dragoco Gerberding Co Ag Verwendung von Dihydropinosylvin und dessen Derivaten als Inhibitoren
US6562791B1 (en) 2002-03-29 2003-05-13 Council Of Scientific And Industrial Research Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
JP2003302761A (ja) * 2002-04-08 2003-10-24 Sumitomo Bakelite Co Ltd ポジ型感光性樹脂組成物及び半導体装置
US6600004B1 (en) * 2002-04-10 2003-07-29 General Electric Company Method of preparing polyestercarbonates
US7705188B2 (en) 2002-04-10 2010-04-27 Arizona Board of Regents, a body corporate of the State of Arizona, Acting for and on Behalf of the Arizona State University Structural modification of resveratrol: sodium resverastatin phosphate
CN1462739A (zh) 2002-05-30 2003-12-24 浙江工业大学 2,2'－二氨基联苄二磷酸盐低压液相催化加氢制备方法
US6852310B2 (en) 2002-08-23 2005-02-08 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Skin lightening agents, compositions and methods
NZ541479A (en) * 2003-02-11 2008-11-28 Vernalis Cambridge Liimited Isoxazole compounds as inhibitors of heat shock proteins
CN1238361C (zh) 2003-02-21 2006-01-25 南开大学 螺环双膦配体
DE10324566A1 (de) * 2003-05-30 2004-12-16 Symrise Gmbh & Co. Kg Verwendung von Diphenylmethan-Derivaten als Tyrosinase-Inhibitoren
JP4569211B2 (ja) * 2003-07-31 2010-10-27 住友ベークライト株式会社 フェノール化合物、ポジ型感光性樹脂組成物、半導体装置及び表示素子、並びに半導体装置及び表示素子の製造方法
JP2005097144A (ja) * 2003-09-24 2005-04-14 Mitsubishi Chemicals Corp ２核フェノール類の製造方法
PL1748767T3 (pl) * 2004-05-28 2012-08-31 Unigen Inc 1-(3-metylo-2,4-dimetoksyfenylo)-3-(2',4'-dihydroksyfenylo)-propan jako silny inhibitor tyrozynazy
US20050271608A1 (en) 2004-06-05 2005-12-08 Gupta Shyam K Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives
DE102004036047A1 (de) * 2004-07-24 2006-02-23 Bioghurt Biogarde Gmbh & Co. Kg Physiologisch aktive Zusammensetzung
US7334392B2 (en) 2004-10-29 2008-02-26 General Electric Company Counter-rotating gas turbine engine and method of assembling same
EP2368442B1 (en) * 2005-07-27 2014-12-17 Symrise AG Use of hesperetin for enhancing the sweet taste
JP2007121873A (ja) * 2005-10-31 2007-05-17 Fujifilm Corp 感光性樹脂組成物及びそれを用いた半導体装置の製造方法
JP5244400B2 (ja) * 2005-12-26 2013-07-24 株式会社林原 アルキルレゾルシノール配糖体とその製造方法並びに用途
JP4986110B2 (ja) * 2006-01-12 2012-07-25 国立大学法人九州大学 レゾルシノール誘導体を含有するメラニン生成抑制剤
US20070224301A1 (en) * 2006-03-21 2007-09-27 Ribnicky David M Compounds from an extract of Artemisia and methods for treating disorders
FR2900047B1 (fr) * 2006-04-21 2012-11-30 Oreal Utilisation d'un derive diphenyl-methane pour le soin des peaux grasses
JP5150894B2 (ja) 2006-08-03 2013-02-27 国立大学法人宇都宮大学 チロシナーゼの活性阻害剤とその製造方法
US7781410B2 (en) 2006-08-04 2010-08-24 Johnson & Johnson Consumer Companies, Inc. Compositions containing chalcones and use thereof
US7339076B1 (en) 2006-11-28 2008-03-04 E.I. Du Pont De Nemours And Company Process for the synthesis of 2,5-dihydroxyterephthalic acid
CN101215306A (zh) * 2008-01-07 2008-07-09 中国科学院昆明植物研究所 熊果苷糖酯衍生物,其组合物和其应用
US8449936B2 (en) * 2008-02-25 2013-05-28 Givaudan Sa Flavor molecules
US8715761B2 (en) * 2008-02-25 2014-05-06 Givaudan S.A. Flavor molecules
JP2011528719A (ja) 2008-07-21 2011-11-24 ユニジェン・インコーポレーテッド スキンホワイトニング（色を薄くする）化合物系列
KR102113823B1 (ko) 2011-03-24 2020-05-21 유니젠, 인크. 디아릴프로판의 제조를 위한 화합물 및 방법

Also Published As

Publication number Publication date
US20170275224A1 (en) 2017-09-28
AU2017210581B2 (en) 2019-06-27
AU2009274158B2 (en) 2016-02-11
US20210188751A1 (en) 2021-06-24
CN102838460B (zh) 2016-08-03
JP7307107B2 (ja) 2023-07-11
US20100016347A1 (en) 2010-01-21
CA2730265A1 (en) 2010-01-28
ES2740974T3 (es) 2020-02-07
AU2016203045B2 (en) 2017-05-04
JP2017114878A (ja) 2017-06-29
AU2009274158A1 (en) 2010-01-28
WO2010011630A1 (en) 2010-01-28
CN102099001A (zh) 2011-06-15
KR20210077013A (ko) 2021-06-24
AU2019232820A1 (en) 2019-10-10
AU2021202804B2 (en) 2023-01-12
JP6321840B2 (ja) 2018-05-09
KR101988329B1 (ko) 2019-06-12
JP6212516B2 (ja) 2017-10-11
JP2020015740A (ja) 2020-01-30
KR102527742B1 (ko) 2023-04-28
KR102107460B1 (ko) 2020-05-08
US8658838B2 (en) 2014-02-25
JP2011528719A (ja) 2011-11-24
EP2323612A1 (en) 2011-05-25
KR20110059835A (ko) 2011-06-07
EP4046619A1 (en) 2022-08-24
US9682910B2 (en) 2017-06-20
EP3542780B1 (en) 2022-01-19
US20230399282A1 (en) 2023-12-14
AU2009274158C1 (en) 2019-09-05
TWI531381B (zh) 2016-05-01
EP3542780A1 (en) 2019-09-25
AU2019232820B2 (en) 2021-02-04
US11739040B2 (en) 2023-08-29
ES2909484T3 (es) 2022-05-06
JP2021098712A (ja) 2021-07-01
KR20180041253A (ko) 2018-04-23
CN102838460A (zh) 2012-12-26
JP6843197B2 (ja) 2021-03-17
AU2021202804A1 (en) 2021-06-03
KR20190067941A (ko) 2019-06-17
KR101849695B1 (ko) 2018-04-17
KR20160116038A (ko) 2016-10-06
TW201018491A (en) 2010-05-16
KR101661608B1 (ko) 2016-09-30
KR102397221B1 (ko) 2022-05-12
US9096507B2 (en) 2015-08-04
JP2015221805A (ja) 2015-12-10
US20160083322A1 (en) 2016-03-24
BRPI0916188A2 (pt) 2017-08-29
US10259764B2 (en) 2019-04-16
JP2018154625A (ja) 2018-10-04
AU2016203045C1 (en) 2018-06-07
AU2016203045A1 (en) 2016-06-02
EP2323612B1 (en) 2019-07-10
KR20200049891A (ko) 2020-05-08
US8362305B2 (en) 2013-01-29
ZA201100043B (en) 2012-10-31
CA2730265C (en) 2016-06-28
PL3542780T3 (pl) 2022-05-02
JP2023058555A (ja) 2023-04-25
AU2017210581A1 (en) 2017-08-24
US20130209383A1 (en) 2013-08-15
KR20220066184A (ko) 2022-05-23
US20190233359A1 (en) 2019-08-01
US10941098B2 (en) 2021-03-09
EP2323612A4 (en) 2014-05-21
US20140363388A1 (en) 2014-12-11
JP6581237B2 (ja) 2019-09-25

Similar Documents

Publication Publication Date Title
HK1179942A1 (zh) 皮膚增白 增亮 化合物系列
PL2313065T3 (pl) Sposoby wybielania zębów
HK1153954A1 (zh) 用於增亮膚色的組合物
HK1159173A1 (zh) 岩藻糖化化合物的合成
EP2280649A4 (en) FABRIC CARRIER OXYMETER
SG10201404148WA (en) Body-worn pulse oximeter
ZA201104045B (en) Cosmetic teeth whitening
EP2521531A4 (en) SKIN LIGHTENING COMPOSITIONS
HK1156867A1 (en) External preparation for skin
IL213694A (en) Melanin suppressant compounds
HK1143758A1 (en) Preparation for external application to skin
IL196212A0 (en) Carotenoid compositions useful for whitening skin
ZA201104223B (en) Skin lightening compositions with acetylcholinesterase inhibitors
IL211052A0 (en) Synthesis of glatiramer acetate
ZA201100123B (en) Bromine-facilitated synthesis of fluoro-sulfur compounds
IL208236A0 (en) Use of cathepsin c
HRP20130652T1 (en) Synthesis of decitabine
IL202145A0 (en) Multiplexing of pulsed sources
ZA201008796B (en) A method of lightening skin
ZA201103078B (en) Use of escin for treatment of type iv hypersensitivity reaction
GB0823366D0 (en) Synthesis
EP2156820A4 (en) SKIN WHITENING AGENT
GB2471281B (en) Whitening toothbrush
GB0821478D0 (en) Novel skin brightening agents
ZA200900158B (en) Improved skin lightening cosmetic composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200717